These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 38157140)

  • 1. Advancements in Bullous Pemphigoid Treatment: A Comprehensive Pipeline Update.
    Karakioulaki M; Eyerich K; Patsatsi A
    Am J Clin Dermatol; 2024 Mar; 25(2):195-212. PubMed ID: 38157140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting interleukin 4 and interleukin 13: a novel therapeutic approach in bullous pemphigoid.
    Chen F; Wang Y; Chen X; Yang N; Li L
    Ann Med; 2023 Dec; 55(1):1156-1170. PubMed ID: 36999962
    [No Abstract]   [Full Text] [Related]  

  • 3. Omalizumab as a corticosteroid-sparing agent in the treatment of bullous pemphigoid.
    Vassallo C; Somenzi A; De Amici M; Barruscotti S; Brazzelli V
    Dermatol Ther; 2022 Dec; 35(12):e15946. PubMed ID: 36259470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a role of eosinophils in blister formation in bullous pemphigoid.
    de Graauw E; Sitaru C; Horn M; Borradori L; Yousefi S; Simon HU; Simon D
    Allergy; 2017 Jul; 72(7):1105-1113. PubMed ID: 28135772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoreactive Peripheral Blood T Helper Cell Responses in Bullous Pemphigoid and Elderly Patients With Pruritic Disorders.
    Didona D; Scarsella L; Fehresti M; Solimani F; Juratli HA; Göbel M; Mühlenbein S; Holiangu L; Pieper J; Korff V; Schmidt T; Sitaru C; Eming R; Hertl M; Pollmann R
    Front Immunol; 2021; 12():569287. PubMed ID: 33841390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bullous pemphigoid].
    Schulze F; Kasperkiewicz M; Zillikens D; Schmidt E
    Hautarzt; 2013 Dec; 64(12):931-43; quiz 944-5. PubMed ID: 24337308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bullous pemphigoid: diagnosis and therapy].
    Kneisel A; Hertl M
    Wien Med Wochenschr; 2014 Sep; 164(17-18):363-71. PubMed ID: 25077677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical manifestations in 100 Japanese bullous pemphigoid cases in relation to autoantigen profiles.
    Tanaka M; Hashimoto T; Dykes PJ; Nishikawa T
    Clin Exp Dermatol; 1996 Jan; 21(1):23-7. PubMed ID: 8689764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Childhood bullous pemphigoid: a clinicopathologic study and review of the literature.
    Fisler RE; Saeb M; Liang MG; Howard RM; McKee PH
    Am J Dermatopathol; 2003 Jun; 25(3):183-9. PubMed ID: 12775979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bullous Pemphigoid: A Review of its Diagnosis, Associations and Treatment.
    Bernard P; Antonicelli F
    Am J Clin Dermatol; 2017 Aug; 18(4):513-528. PubMed ID: 28247089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bullous pemphigoid (BP) patients with selective IgG autoreactivity against BP230: Review of a rare but valuable cohort with impact on the comprehension of the pathogenesis of BP.
    Ramcke T; Vicari E; Bolduan V; Enk A; Hadaschik E
    J Dermatol Sci; 2022 Feb; 105(2):72-79. PubMed ID: 34930674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of Dupilumab in Moderate-to-Severe Bullous Pemphigoid.
    Zhang Y; Xu Q; Chen L; Chen J; Zhang J; Zou Y; Gong T; Ji C
    Front Immunol; 2021; 12():738907. PubMed ID: 34721404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging treatments for bullous pemphigoid.
    Garrido PM; QueiróS CS; Travassos AR; Borges-Costa J; Filipe P
    J Dermatolog Treat; 2022 Mar; 33(2):649-661. PubMed ID: 32536232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advancing Treatment in Bullous Pemphigoid: A Comprehensive Review of Novel Therapeutic Targets and Approaches.
    Chen HC; Wang CW; Toh WH; Lee HE; Chung WH; Chen CB
    Clin Rev Allergy Immunol; 2023 Dec; 65(3):331-353. PubMed ID: 37897588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgE blockade in autoimmunity: Omalizumab induced remission of bullous pemphigoid.
    James T; Salman S; Stevenson B; Bundell C; Kelly G; Nolan D; John M
    Clin Immunol; 2019 Jan; 198():54-56. PubMed ID: 30557620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of autoantibodies against BP180/BP230 in response to topical corticosteroids in patients with bullous pemphigoid.
    Schneiderbauer R; Martinache S; Engstner M; Enk AH; Hadaschik EN
    Dermatol Ther; 2016 Nov; 29(6):419-423. PubMed ID: 27550573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulin E and bullous pemphigoid.
    Cozzani E; Gasparini G; Di Zenzo G; Parodi A
    Eur J Dermatol; 2018 Aug; 28(4):440-448. PubMed ID: 30325326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of bullous pemphigoid developing under treatment with benralizumab for bronchial asthma.
    Tanaka A; Fujimura Y; Fuke S; Izumi K; Ujiie H
    J Dermatol; 2023 Sep; 50(9):1199-1202. PubMed ID: 37122191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence-based management of bullous pemphigoid.
    Daniel BS; Borradori L; Hall RP; Murrell DF
    Dermatol Clin; 2011 Oct; 29(4):613-20. PubMed ID: 21925006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eosinophils in bullous pemphigoid.
    Jones VA; Patel PM; Amber KT
    Panminerva Med; 2021 Sep; 63(3):368-378. PubMed ID: 32536149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.